NCT00548171View on ClinicalTrials.gov

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

PHASE4CompletedINTERVENTIONAL

Enrollment

203

Participants

Timeline

Start Date

November 5, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Acellular PertussisTetanusDiphtheriaDiphtheria-Tetanus-acellular Pertussis Vaccines

Interventions

BIOLOGICAL

Boostrix™

Intramuscular injection, 1 dose

Trial Locations (1)

2145

GSK Investigational Site, Westmead

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY